VEGFA and macular retinal edema: From the perspective of anatomical and pathological factors, CRVA treatment can still be tried, and it can be combined with anti-VEGF therapy, particularly for recurrent and refractory RVO complications such as macular edema and neovascularization, which may have better results than anti-VEGF treatment alone.